Exicure (NASDAQ:XCUR) Stock Price Down 1.6% – Time to Sell?

Shares of Exicure, Inc. (NASDAQ:XCUR) traded down 1.6% during trading on Thursday . The company traded as low as $8.40 and last traded at $8.44. 4,577 shares were traded during mid-day trading, a decline of 95% from the average session volume of 87,654 shares. The stock had previously closed at $8.58.

Exicure Stock Performance

The company’s fifty day moving average is $12.32 and its two-hundred day moving average is $8.01. The firm has a market cap of $22.03 million, a price-to-earnings ratio of -4.08 and a beta of 3.76.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Exicure stock. Geode Capital Management LLC acquired a new stake in Exicure, Inc. (NASDAQ:XCUR) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,645 shares of the company’s stock, valued at approximately $173,000. Geode Capital Management LLC owned about 0.48% of Exicure at the end of the most recent reporting period. 42.82% of the stock is currently owned by institutional investors.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.